Profiling antibodies for RSV infection and vaccination
Official title: TASK V13: DEEP ANTIBODY PROFILING FOR RSV INFECTION AND VACCINATION
Funded at Battelle Centers/pub Hlth Res & Evaluatn · NIH-10683814 · Data updated 2026-11-12
This study is working on new vaccines to help protect against Respiratory Syncytial Virus (RSV), and it's for anyone who wants better ways to prevent this infection, especially for those at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Centers/pub Hlth Res & Evaluatn NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project start | September 12, 2018 |
| Project end | September 11, 2028 |
| Funding year | 2022 |
| Award (this year) | $787,348 |
| NIH project number | 272201800013I-0-759302200002-1 |
| Project ID | NIH-10683814 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include infants, young children, and individuals with compromised immune systems who are at higher risk for RSV infection.
✕Less likely to help
Patients who are not at risk for RSV infection or those who have already been vaccinated against RSV may not receive significant benefits from this research.
What this research studies
This research focuses on developing and evaluating new vaccine candidates and biologics for Respiratory Syncytial Virus (RSV) infection. It involves conducting feasibility studies and providing essential services for the submission of applications required to bring these vaccines to market. Patients may benefit from advancements in vaccine technology that could lead to more effective prevention strategies against RSV. The research aims to enhance our understanding of antibody responses to RSV, which is crucial for vaccine development.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against RSV, potentially reducing the incidence and severity of infections in vulnerable populations.
How similar studies have gone: Previous research has shown success in developing vaccines for other infectious diseases using similar antibody profiling approaches, indicating a promising avenue for RSV vaccine development.
Where this research is happening
-
Battelle Centers/pub Hlth Res & Evaluatn
Columbus, United States Active
Researchers
- Principal investigator: Rudge, Thomas — Battelle Centers/pub Hlth Res & Evaluatn
- Study coordinator: Rudge, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Protective dengue vaccines that steer T and B cell responses
A vaccine study aims to guide the body’s T and B cells to fight all four dengue virus types safely and effectively.
-
Respiratory pathogen–specific T cell signatures after vaccination, infection, and treatment
A research effort to map how immune T cells respond to respiratory infections and vaccines, with potential to guide better vaccines and treatments for conditions like covid-19 and pertussis.
-
Malaria vaccine and infection: how the body’s early and later immune responses relate to protection
Researchers are studying how people’s immune systems respond to the malaria pre-erythrocytic stage, whether after vaccination or infection, to identify which responses are linked to protection.
-
Spatially responsive mass vaccination for urban rabies
A new plan uses data and maps to place vaccination sites where they’re most needed in cities, aiming to boost rabies vaccination for both people and dogs.
-
Spatially responsive mass vaccination for urban rabies
A project tests smarter placement of vaccination sites to increase mass canine rabies vaccination in cities.
-
Vaccine failure after Covid-19 vaccination in older adults
This project follows vaccinated older adults to understand who among them still gets Covid-19 and what factors make those outcomes worse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.